Skip to main content
Clinical Trials/DRKS00009862
DRKS00009862
Completed
Phase 2

Treatment program including a smartphone app addressing adolescents with problems in academic achievement and mental health problems in Cologne

Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters der Uniklinik Köln (AKiP)0 sites60 target enrollmentApril 18, 2016

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
F40
Sponsor
Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters der Uniklinik Köln (AKiP)
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 18, 2016
End Date
November 7, 2019
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters der Uniklinik Köln (AKiP)

Eligibility Criteria

Inclusion Criteria

  • 1 Student of a secondary school
  • 2\. Adequate schooling based on intellectual abilities (German School System:
  • Hauptschule (basic level) \- GIQ \> \= 85;
  • Realschule (medium level) \- GIQ \> \= 90;
  • Gymnasium (high level) \- GIQ \> \= 105
  • Gesamtschule (Comprehensive schools): School recommendation or Basic Courses GIQ \= 85 \& Advanced courses GIQ \= 105
  • 3\. Poor academic performance, which must be in the center of the problems reported
  • 4\. Grades beyond intellectuals abilities\- last school report either 1\*5 \& 1\*4 OR 3\*4 (1\=very good, 5\= unsatisfactory)
  • 5\. Academic achievement problems (measured with SELBST\- 6M (adolescent, parent and teacher) at least one questionnaire average value \>\=1\.5
  • 6\. One of the following diagnoses: depression, ADHD, anxiety or conduct disorder

Exclusion Criteria

  • 1\. No need for inpatient treatment
  • 2\. None of the following diagnoses: psychotic disorder, acute suicidality or endangerment of others, autism spectrum disorder, eating disorder or severe substance abuse
  • 3\. In case of pharmacotherapy then no change of medication or dosage for 12 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials